Tag | Content |
---|
EnhancerAtlas ID | HS150-02075 |
Organism | Homo sapiens |
Tissue/cell | NT2-D1 |
Coordinate | chr11:8093570-8094410 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr11:8093854-8093872 | TCTCCCTTCCTTCCCTTC | - | 6.09 | EWSR1-FLI1 | MA0149.1 | chr11:8093858-8093876 | CCTTCCTTCCCTTCCTCC | - | 7.36 | GLI2 | MA0734.2 | chr11:8093994-8094009 | TGACCACCCACAGTG | + | 6.25 | ZNF263 | MA0528.1 | chr11:8093855-8093876 | CTCCCTTCCTTCCCTTCCTCC | - | 7.12 | ZNF263 | MA0528.1 | chr11:8093858-8093879 | CCTTCCTTCCCTTCCTCCCTC | - | 8.21 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_08581 | chr11:8092475-8094061 | Brain_Inferior_Temporal_Lobe |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr11 | 8093600 | 8094000 | chr11 | 8094000 | 8094366 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I008070 | chr11 | 8092476 | 8094061 |
|
Enhancer Sequence | GATGGAGGTA CAGGAAGGGG CCACTCTGCA GCAGCGGAGA GGGTGGTGAC AGCTCAGCAG 60 ACACAGAGAC ATGGAGAGCA GGTGGGCTGT GATCGGACCA GGAGTCGGGA GAGAGACACA 120 GTGATGCAAA GGACGCAGAG GGGGAAGGAG GCAGAGGCGG GTACTGCCCC ACAGCCCCAC 180 CACCCCTGGG CGTGATCTCA CCTGAGGAAG CCTAGAAGGA GTCTTCACGC GTCGCCTCCT 240 CCAGGCCAGA GCTCAGCTTG GAGATGCAGA GGGGGAAGGG ACCCTCTCCC TTCCTTCCCT 300 TCCTCCCTCC TAGAGCCTAG GCAGGGCAGC AGTGGTGGGA CCACCTGTTC TCACCCTCAT 360 CTGCGGTGGG CGGCGGAGGC CCCATGCCAC AGGCTTGGTG AGGCTGAGTA AATCCTTGCT 420 GCTGTGACCA CCCACAGTGC TTCTGCTTCC TTCTGTATAA TAGCTCCTCG GGGAGCTGCC 480 AGCAATCAAT GAGACAATAC AAGCGAGCAC TTAGCACAGT GCTGGCCCTG TGTGAGGGCT 540 CAGTGAGTGG GAGCTCTAAG TACTAAATGT TGTCCCATCT CCGTGGTGCT TTGGACTTCC 600 AGCACAGCAT TCACAGACAC ACGTCCCTTC TCAGTTCATC CTCACACACT ATGTGCAGTA 660 GGCAAGGAAT ACGTTGTCTC CAATCAACAG ATGAGGAAAC TGAGGCGAGC CTGGGGAAAG 720 TGGTCTCTGG TCACCCAGTG AGTTAGCAGC AGAGAGGATA AGAATTCAGC TCCCCTCAGT 780 CTTGTGTGTT TTCACAGCTG TGTTTCTTAC ATAAAATACA AGAATGCTAA CACAAAAAAC 840
|